Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 07, 2015 12:02 AM ET


Company Overview of Virobay Inc.

Key Executives for Virobay Inc.

NameBoard RelationshipsTitleAge
Robert F. G. Booth Ph.D.22 RelationshipsCo-Founder, Chairman, Chief Executive Officer, President and Secretary61
Heather Preston M.D.52 RelationshipsCo-Founder, Director, Chairperson of Nominating & Corporate Governance Committee and Member of Audit Committee49
Kyle C. Elrod B.A.No RelationshipsSenior Vice President of Project Management and Operations48
Elizabeth G. Shigezumi No RelationshipsHead of Clinical Operations and Clinical Trial Manager of Clinical Operations56

Virobay Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Robert F. G. Booth Ph.D. 22 RelationshipsVirobay Inc.61
Heather Preston M.D. 52 RelationshipsVirobay Inc.49
Thomas John Dietz Ph.D. 57 RelationshipsGalleon Pharmaceuticals, Inc.51
Daniel S. Janney MBA 63 RelationshipsAlta Partners LP49
Jeffrey W. Bird M.D., Ph.D. 96 RelationshipsVerinata Health, Inc.54
View All Board Members

Virobay Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Ph.D.Thomas John Dietz57 Relationships3 Executives
Compensation Committee Ph.D.Thomas John Dietz57 Relationships3 Executives
Nominating Committee M.D.Heather Preston52 Relationships3 Executives
Corporate Governance Committee M.D.Heather Preston52 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$355.4K
Compensation as of Fiscal Year 2013
Virobay Inc. CEO Compensation
Industry Average


SC Johnson Appoints Ann Mukherjee as Global Chief Marketing Officer
October 02, 2015 12:00 AM ET
Spectrum Brands Holdings, Inc. Announces Changes to the Board of Directors
September 28, 2015 12:00 PM ET
Mary Agnes Wilderotter Does Not Stand for Re-Election to Board of Directors of The Procter & Gamble Company
September 25, 2015 8:00 PM ET
The National Detergent Company S.A.O.G. Announces Board Changes
September 21, 2015 7:50 AM ET
Procter & Gamble Announces Retirement of Tarek Farahat as President of Latin America Selling and Market Operations
September 18, 2015 4:32 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Virobay Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at